Stocks

Vuzix has brought augmented reality to Japanese hospitals. Shares have risen in price

Vuzix Corporation (VUZI) continues to turn its augmented reality (AR) glasses into a standard for medical use. Taking advantage of…

Read More »

Regeneron Pharmaceuticals Biotech is waiting for the FDA’s decision

The biotech company Regeneron Pharmaceuticals Inc. (REGN) has applied to the FDA to approve the drug Libtayo as a therapy for a…

Read More »

Strong report Monday.com led to a double-digit increase in quotations

Shares of an enterprise software provider Monday.com Ltd. (MNDY), rose by more than 17% at auction on August 11 after the…

Read More »

Sorento Therapeutics has provided several quotes

The biotech company Sorrento Therapeutics Inc. (SRNE) saw its shares rise after the company announced the commencement of COVID-19 nasal…

Read More »

What to expect from Johnson & Johnson’s pharmaceutical business?

Johnson & Johnson (NYSE: JNJ) has a portfolio of in-demand pharmaceuticals, some of which are about to expire. However, they…

Read More »

Will InMode be able to realize its competitive advantages?

The developer of equipment for aesthetic procedures InMode Ltd. (INMD) has many key advantages that would help to gain a substantial market…

Read More »

Casino operator MGM Resorts is striving for more significant influence in the online betting market

The MGM Resorts International casino chain (NYSE: MGM) is seeking to obtain a controlling stake in the BetMGM online betting…

Read More »

US stock indices rose

The New York Stock Exchange rose on Thursday to close trading amid data showing an improvement in the US labor…

Read More »

Company T-Mobile is ahead of its competitors in 5G

Company T-Mobile U.S. Inc. (TMUS) is accelerating the deployment of the 5G network. At the same time, the company is…

Read More »

Regeneron Pharmaceuticals’ sales are going down, but the company has plans to make up for it

The revenue of the pharmaceutical company Regeneron Pharmaceuticals Inc. (REGN) dropped sharply in the last quarter, both compared to the…

Read More »
Back to top button